Last reviewed · How we verify

Fish oil emulsion — Competitive Intelligence Brief

Fish oil emulsion (Fish oil emulsion) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nutritional supplement / Lipid emulsion. Area: Nutrition / Critical care / Immunomodulation.

phase 3 Nutritional supplement / Lipid emulsion Nutrition / Critical care / Immunomodulation Small molecule Live · refreshed every 30 min

Target snapshot

Fish oil emulsion (Fish oil emulsion) — Centre Hospitalier Universitaire Vaudois. Fish oil emulsion delivers omega-3 polyunsaturated fatty acids (EPA and DHA) that reduce inflammation and modulate immune and metabolic pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fish oil emulsion TARGET Fish oil emulsion Centre Hospitalier Universitaire Vaudois phase 3 Nutritional supplement / Lipid emulsion

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nutritional supplement / Lipid emulsion class)

  1. Centre Hospitalier Universitaire Vaudois · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fish oil emulsion — Competitive Intelligence Brief. https://druglandscape.com/ci/fish-oil-emulsion. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing